GLP-1 agonists could lead to worse metabolic health, including significant loss of muscle mass
Hirono WJS, Miki A, Shiozawa M et al (2023) The Efficacy and Safety of Somatostatin Analog after Axillary Node Dissection in Breast Cancer: A Systematic Review and Meta-analysis
Track body measurements, energy levels, sleep quality, appetite changes, and how your clothes fit
At the start of GLP-1 RA medications, some people may experience side effects of semaglutide, tirzepatide, and other GLP-1 RAs which include nausea, vomiting, abdominal pain, bloating, constipation or diarrhea, weakness during exercise, and headaches
The research described on this page concerns the two molecules in published studies, not a Form Labs product
The titration process is designed to balance therapeutic effectiveness with tolerability